Literature DB >> 21695661

[New recommendations for contact tracing in tuberculosis].

R Diel1, G Loytved, A Nienhaus, S Castell, A Detjen, H Geerdes-Fenge, W Haas, B Hauer, B Königstein, D Maffei, K Magdorf, M Priwitzer, J-P Zellweger, R Loddenkemper.   

Abstract

In 2007, the German Central Committee against Tuberculosis (DZK) published recommendations for contact tracing that introduced the new interferon gamma release assays (IGRAs). Meanwhile, substantial progress has been made in documenting the utility of IGRAs. Because IGRAs are usually superior to the tuberculin skin test (TST) in detecting latent TB infection (LTBI) with respect to sensitivity and specificity in adult contact populations that are at least partially BCG vaccinated, it is now recommended that instead of two-step testing only IGRAs be used.[nl]As the literature does not yet provide sufficient data on the accuracy of IGRAs in children younger than 5 years, the TST remains the method of choice in that age group. To date, also, no clear body of data exists to substantiate better performance for IGRAs than for the TST in older children, thus in this age group using of either test is recommended. The new recommendations also underscore the importance of a diligent preselection of close contacts in order to achieve a high probability that positive test results represent recent infection and to thus increase the benefit of chemopreventive treatment for those identified as requiring it. In a third point of update, it is noted that re-testing of contacts individuals found positive for LTBI may produce a considerable number of false-negative results and should thus be avoided in case of documented exposure. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21695661     DOI: 10.1055/s-0030-1256574

Source DB:  PubMed          Journal:  Gesundheitswesen        ISSN: 0941-3790


  5 in total

1.  Donor-derived tuberculosis after solid organ transplantation in two patients and a staff member.

Authors:  J N Bucher; M B Schoenberg; I Freytag; U Lange; S Hofmann-Thiel; M O Guba; J Werner; A Eder; G Schelling; M Stangl
Journal:  Infection       Date:  2015-10-23       Impact factor: 3.553

2.  Assessing the utility of contact tracing in reducing the magnitude of tuberculosis.

Authors:  Saurabh R Shrivastava; Prateek S Shrivastava; Jegadeesh Ramasamy
Journal:  Infect Ecol Epidemiol       Date:  2014-10-23

3.  Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany.

Authors:  Christian Gutsfeld; Ioana D Olaru; Oliver Vollrath; Christoph Lange
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

4.  A joint cross-border investigation of a cluster of multidrug-resistant tuberculosis in Austria, Romania and Germany in 2014 using classic, genotyping and whole genome sequencing methods: lessons learnt.

Authors:  Lena Fiebig; Thomas A Kohl; Odette Popovici; Margarita Mühlenfeld; Alexander Indra; Daniela Homorodean; Domnica Chiotan; Elvira Richter; Sabine Rüsch-Gerdes; Beatrix Schmidgruber; Patrick Beckert; Barbara Hauer; Stefan Niemann; Franz Allerberger; Walter Haas
Journal:  Euro Surveill       Date:  2017-01-12

5.  Cost of illness of non-multidrug-resistant tuberculosis in Germany: an update.

Authors:  Roland Diel; Albert Nienhaus
Journal:  ERJ Open Res       Date:  2020-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.